First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (FBT) Competitors GBX 1,500.48 +2.28 (+0.15%) As of 05/21/2025 04:31 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock FBT vs. TRST, PRSM, KAPE, KNOS, LTG, ALFA, GBG, ATG, CER, and IMOShould you be buying First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation stock or one of its competitors? The main competitors of First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation include Trustpilot Group (TRST), Blue Prism Group (PRSM), Kape Technologies (KAPE), Kainos Group (KNOS), Learning Technologies Group (LTG), Alfa Financial Software (ALFA), GB Group (GBG), Auction Technology Group (ATG), Cerillion (CER), and IMImobile (IMO). These companies are all part of the "software - application" industry. First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation vs. Trustpilot Group Blue Prism Group Kape Technologies Kainos Group Learning Technologies Group Alfa Financial Software GB Group Auction Technology Group Cerillion IMImobile First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) and Trustpilot Group (LON:TRST) are both small-cap computer and technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, valuation, community ranking, profitability, media sentiment and institutional ownership. Which has stronger earnings & valuation, FBT or TRST? Trustpilot Group has higher revenue and earnings than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation. First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation is trading at a lower price-to-earnings ratio than Trustpilot Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFirst Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationN/AN/AN/A-£1.10-1,364.07Trustpilot Group£222.55M5.61£20.08M£3.0278.96 Is FBT or TRST more profitable? Trustpilot Group has a net margin of 9.02% compared to First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation's net margin of 0.00%. Trustpilot Group's return on equity of 29.53% beat First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation's return on equity.Company Net Margins Return on Equity Return on Assets First Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationN/A N/A N/A Trustpilot Group 9.02%29.53%1.45% Does the MarketBeat Community prefer FBT or TRST? First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation received 47 more outperform votes than Trustpilot Group when rated by MarketBeat users. However, 75.76% of users gave Trustpilot Group an outperform vote while only 66.67% of users gave First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation an outperform vote. CompanyUnderperformOutperformFirst Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationOutperform Votes7266.67% Underperform Votes3633.33% Trustpilot GroupOutperform Votes2575.76% Underperform Votes824.24% Does the media favor FBT or TRST? In the previous week, Trustpilot Group had 2 more articles in the media than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation. MarketBeat recorded 2 mentions for Trustpilot Group and 0 mentions for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation. Trustpilot Group's average media sentiment score of 0.30 beat First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation's score of 0.00 indicating that Trustpilot Group is being referred to more favorably in the news media. Company Overall Sentiment First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Neutral Trustpilot Group Neutral Do insiders and institutionals hold more shares of FBT or TRST? 78.2% of Trustpilot Group shares are owned by institutional investors. 8.2% of Trustpilot Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Do analysts recommend FBT or TRST? Trustpilot Group has a consensus price target of GBX 335, suggesting a potential upside of 40.64%. Given Trustpilot Group's stronger consensus rating and higher possible upside, analysts plainly believe Trustpilot Group is more favorable than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Trustpilot Group 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryTrustpilot Group beats First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation on 14 of the 15 factors compared between the two stocks. Get First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation News Delivered to You Automatically Sign up to receive the latest news and ratings for FBT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FBT vs. The Competition Export to ExcelMetricFirst Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationSoftware IndustryComputer SectorLON ExchangeMarket Cap£615.52M£5.34B£25.10B£2.66BDividend YieldN/A3.20%2.90%5.05%P/E Ratio-1,364.0728.5044.59134.04Price / SalesN/A276.191,997.44215,627.72Price / Cash3.5416.6334.7828.02Price / BookN/A9.636.653.80Net IncomeN/A£63.43M£739.99M£5.88B7 Day Performance5.27%0.53%-0.92%0.50%1 Month Performance7.70%12.84%12.60%21.94%1 Year Performance0.86%9.60%52,628.86%119.00% First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FBTFirst Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationN/AGBX 1,500.48+0.2%N/A+2.3%£615.52MN/A-1,364.0720TRSTTrustpilot Group2.0884 of 5 starsGBX 252.20+0.1%GBX 335+32.8%+11.7%£1.32B£222.55M83.60820PRSMBlue Prism GroupN/AN/AN/AN/A£1.24B£167.30M-23.681,025High Trading VolumeKAPEKape TechnologiesN/AN/AN/AN/A£1.22B£623.48M1,900.00850Gap DownKNOSKainos Group3.3235 of 5 starsGBX 815+0.8%GBX 1,070+31.3%-41.5%£1.03B£383.18M21.362,953News CoverageEarnings ReportAnalyst ForecastLTGLearning Technologies GroupN/AN/AGBX 90+∞N/A£792.10M£529.20M16.755,001ALFAAlfa Financial SoftwareN/AGBX 242.50+1.9%N/A+41.9%£726.24M£103.11M32.78475Gap UpGBGGB Group2.1311 of 5 starsGBX 280.50+1.6%GBX 395+40.8%-20.1%£707.49M£276.95M-14.561,183News CoverageATGAuction Technology Group1.6033 of 5 starsGBX 547-1.1%GBX 680+24.3%-23.7%£675.74M£136.68M66.81396CERCerillion2.5314 of 5 starsGBX 1,730+0.6%N/A+18.8%£513.04M£41.39M36.47321Earnings ReportDividend IncreaseAnalyst ForecastHigh Trading VolumeIMOIMImobileN/AN/AN/AN/A£490.40M£164.04M123.755,300 Related Companies and Tools Related Companies Trustpilot Group Competitors Blue Prism Group Competitors Kape Technologies Competitors Kainos Group Competitors Learning Technologies Group Competitors Alfa Financial Software Competitors GB Group Competitors Auction Technology Group Competitors Cerillion Competitors IMImobile Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:FBT) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.